Alvotech and Advanz Pharma extend strategic partnership to commercialize five proposed biosimilars in EuropeExclusive Partnership Agreement • May 24th, 2023
Contract Type FiledMay 24th, 2023The agreement includes proposed biosimilars to Simponi® (golimumab), Entyvio® (vedolizumab) and three additional early-stage undisclosed biosimilar candidates